The biomaterials market was valued at USD 167.39 Billion in 2025. It is poised to grow at a CAGR of 14.20% during the forecast period of 2026-2035, and reach USD 631.53 Billion by 2035. The market growth is driven by the growing demand for implants and prosthetics, advancements in regenerative medicine, and an increasing aging population, fueling market growth, alongside innovations in biocompatible materials and rising healthcare expenditure worldwide.
Other key players in the market are BASF SE, Covestro AG, Celanese Corporation, Carpenter Technology Corporation, Evonik Industries AG, Victrex plc, Coorstek Inc., and CeramTec GmbH.
Key Market Trends and Insights
- Based on region, North America market held the largest share of around 38% of the global market in the historical period.
- By product, the metallic segment held the largest market share of above 40% during the historical period.
- Based on application, orthopedic segment accounted for the largest revenue share of nearly 24% during the historical period.
Market Size and Forecast
- Market Size (2025): USD 167.39 Billion
- Projected Market Size (2035): USD 631.53 Billion
- CAGR (2026-2035): 14.20%
Biomaterials Market Overview
The biomaterials market is expanding steadily, driven by increasing demand for advanced polymer biomaterial applications in medical devices and implants. Growing use of ceramic biomaterials and collagen-based materials supports orthopedic and cardiovascular treatments. Innovations in degradable biomaterials and tissue engineering scaffolds are enhancing clinical outcomes, while advancements in surface modification are improving implant performance and long-term therapeutic efficiency. The market reached a value of approximately USD 167.39 Billion in 2025.Biomaterials Market Growth Drivers
Growing Focus on Smart Drug Delivery Systems to Propel the Market Demand
Increasing focus on programmable biomaterials is advancing next-generation therapeutics, particularly enhancing hydrogel-based delivery systems. For instance, in January 2026, researchers developed DNA-based hydrogels with tunable degradation and controlled antibody release capabilities. These smart biomaterials allow precise modulation of drug delivery and responsiveness to biological triggers, supporting personalized medicine approaches and enhancing the role of biomaterials in advanced therapeutic systems.Biomaterials Market Trends
Key trends shaping the market include smart biomaterials, injectable hydrogels, microfluidic fabrication, regenerative medicine demand, and growing interdisciplinary research collaborations globally.Technological Advancements in Biomaterials Engineering to Support the Market Expansion
Technological convergence between microfluidics and biomaterials engineering is advancing therapeutic innovation, particularly improving biocompatibility across next-generation solutions. For instance, in February 2026, a study titled “Microfluidic Fabrication of DNA Hydrogels with Controlled Swelling and Dissolution Properties,” published on arXiv, introduced a scalable fabrication approach enabling precise control over hydrogel properties, supporting applications in biosensing, drug delivery, and tissue engineering. These advancements support high-precision applications such as biosensing, targeted drug delivery, and tissue engineering, strengthening the role of engineered biomaterials in translational research.Biomaterials Market Segmentation
Market Breakup by Product Type
- Metallic
- Stainless Steel
- Gold
- Cobalt-Chrome
- Others
- Natural
- Hyaluronic Acid
- Cellulose
- Gelatin
- Others
- Ceramics
- Calcium Phosphate
- Aluminum Oxide
- Glass
- Others
- Polymers
- Polyethylene
- Polyester
- Nylon
- Others
Market Breakup by Application
- Orthopedic
- Orthobiologics
- Viscosupplementation
- Spine Biomaterials
- Others
- Cardiovascular
- Sensors
- Stents
- Pacemakers
- Vascular Grafts
- Others
- Ophthalmology
- Synthetic Corneas
- Intraocular Lens
- Contact Lens
- Ocular Tissue Replacement
- Others
- Dental
- Tissue Regeneration Materials
- Dental Implants
- Grafts and Substitutes
- Others
- Plastic Surgery
- Soft Tissue Fillers
- Peripheral Nerve Repair
- Acellular Dermal Matrices
- Others
- Wound Healing
- Fracture Healing Devices
- Adhesion Barrier
- Internal Tissue Sealant
- Others
- Tissue Engineering
- Neurological/Central Nervous System
- Neural Stem Cell Encapsulation
- Shunting Systems
- Hydrogel Scaffold for CNS Repair
- Cortical Neural Prosthetics
- Others
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Biomaterials Market Share
Metallic Segment Expected to Lead the Market Segment by Product Type
The market share was led by the metallic segment, which held the largest share of above 40% in the historical period. This dominance is attributed to its extensive use in orthopedic and titanium implant applications, along with dental and cardiovascular devices. Strong durability and cost-effectiveness further supported adoption. Increasing demand for advanced medical implants and continuous material innovation also contributed to sustained global growth.Biomaterials Market Analysis by Region
North America held the largest share of around 38% of the global market in the historical period. This leadership is driven by advanced healthcare infrastructure, high adoption of innovative biomaterials, and growing demand for tissue engineering scaffold solutions. Additionally, rising chronic disease prevalence, increasing surgical procedures, and significant R&D investments further strengthened the region’s overall market dominance.Leading Players in the Biomaterials Market
The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Noble Biomaterials Inc.
Noble Biomaterials Inc. is a U.S.-based advanced materials company headquartered in Scranton, Pennsylvania, and founded in 1997. It specializes in antimicrobial and conductive biomaterials used in medical textiles, wound care, and infection control. Its key portfolio includes silver-based technologies like Ionic+® and Circuitex®, widely used in healthcare, military, and performance apparel applications for enhanced protection and biocompatibility.Zimmer Biomet
Zimmer Biomet is a leading U.S. medical device company headquartered in Warsaw, Indiana, established in 1927. It offers a strong biomaterials portfolio focused on orthopedic implants, joint reconstruction, spine systems, and bone graft substitutes. The company is a global leader in regenerative orthopedic solutions, supporting knee, hip, and dental applications with advanced implantable biomaterials and robotic-assisted surgical technologies.Corbion NV
Corbion NV is a Netherlands-based company headquartered in Amsterdam and founded in 1919. It focuses on sustainable biomaterials including lactic acid, polylactic acid (PLA), and biodegradable polymers. Its portfolio supports medical implants, tissue regeneration, drug delivery systems, and orthopedic applications, making it a key player in bio-based and eco-friendly medical material innovations.Koninklijke DSM N.V.
Koninklijke DSM N.V. is a Dutch multinational headquartered in Heerlen, Netherlands, founded in 1902. It provides advanced biomaterials for regenerative medicine, biocompatible polymers, and medical-grade materials. Its portfolio supports tissue engineering, implantable devices, and drug delivery systems, with a strong emphasis on sustainable life sciences solutions and innovative biomedical material development globally.Other key players in the market are BASF SE, Covestro AG, Celanese Corporation, Carpenter Technology Corporation, Evonik Industries AG, Victrex plc, Coorstek Inc., and CeramTec GmbH.
Key Questions Answered in the Biomaterials Market
- What was the biomaterials market value in 2025?
- What is the biomaterials market forecast outlook for 2026-2035?
- What major factors aid the demand for biomaterials market?
- How has the market performed so far, and how is it anticipated to perform in the coming years?
- What are the market’s major drivers, opportunities, and restraints?
- What are the major biomaterials market trends?
- Which product type is expected to dominate the market segment?
- Which application is expected to dominate the market segment?
- Who are the key players in the biomaterials market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
Table of Contents
1 Preface
3 Global Biomaterials Market Overview
4 Vendor Positioning Analysis
5 Global Biomaterials Market Landscape*
6 Global Biomaterials Market Dynamics
7 Global Biomaterials Market Segmentation (219-2035)
8 North America Biomaterials Market (219-2035)
9 Europe Biomaterials Market (219-2035)
10 Asia Pacific Biomaterials Market (219-2035)
11 Latin America Biomaterials Market (219-2035)
12 Middle East and Africa Biomaterials Market (219-2035)
13 Regulatory Framework
14 Patent Analysis
15 Funding and Investment Analysis
16 Strategic Initiatives
17 Supplier Landscape
18 Global Biomaterials Market - Distribution Model (Additional Insight)
Companies Mentioned
- Noble Biomaterials Inc.
- Zimmer Biomet
- Corbion NV
- Koninklijke DSM N.V.
